OpenVSafe by OpenVAERS
Search V-safe

46W-22878-87548

2 vaccinations 3 coded responses 18 check-ins 3 free-text entries 2 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
201 / VA
Registered
2022-07-04
Relationship
Child or adolescent in my care
Guardian
WK4-23136-16460
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-01
    Dose 1 — Pfizer-BioNTech
  2. 2022-07-04
    Registered in v-safe
  3. 2022-07-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-06
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-07
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-08
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-15
    Survey response — day 14, dose 1, under 3
    MedDRA: Cough, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Cold symptoms- runny nose, coughing · Healthcare visit (other): Covid test administered
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-07-15
    Report sent to call center — day 14, dose 1, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2022-07-18
  10. 2022-07-18
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  11. 2022-07-22
    Dose 2 — Pfizer-BioNTech
  12. 2022-07-24
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  13. 2022-07-25
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-07-26
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  15. 2022-07-27
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Poor · Fever · Sleepiness · Be unable to work or attend school
    Free text: Cough and runny nose
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-07-28
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-07-29
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-08-05
    Health check-in — day 14, dose 2, under 3
    Feeling: Fair
    Under 3 check-in
  19. 2022-08-12
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2022-08-19
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-08-26
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-09-04
    Survey response — day 42, dose 2, under 3
    MedDRA: Hand-foot-and-mouth disease — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: He has hand, foot and mouth.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-09-04
    Report sent to call center — day 42, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  24. 2022-09-06
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  25. 2022-10-21
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  26. 2023-01-20
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-01Pfizer-BioNTech No
22022-07-22Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-07-15 Successful
2022-07-18
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-09-04 Successful
2022-09-06
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-15

Symptoms: Cold symptoms- runny nose, coughing
Healthcare visit (other): Covid test administered

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-27

Systemic reaction (other): Cough and runny nose

Release 12 (Under 3) — day 42, dose 2, under 3

2022-09-04

Symptoms: He has hand, foot and mouth.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSARS-CoV-2 test · · ✓
SDCough · · ✓
SDHand-foot-and-mouth disease · · ✓
SDNasopharyngitis · · ✓
SDRhinorrhoea · · ✓
SROCough · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release